93 related articles for article (PubMed ID: 7912801)
41. Hepatitis C after intravenous immunoglobulin.
Sewell WA; Mullighan CG; Christie J; Chapel HM
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):466-7. PubMed ID: 9396984
[No Abstract] [Full Text] [Related]
42. Intravenous immunoglobulin and hepatitis C virus: the British episode.
Healey C; Chapel H
Clin Ther; 1996; 18 Suppl B():93-5. PubMed ID: 8930446
[No Abstract] [Full Text] [Related]
43. Hepatitis C and intravenous immunoglobulin. April 29-30, 1995, Orlando, Florida. Papers from the symposium.
Clin Ther; 1996; 18 Suppl B():1-139. PubMed ID: 9081773
[No Abstract] [Full Text] [Related]
44. The viral safety of intravenous immune globulin.
Yap PL
Clin Exp Immunol; 1996 May; 104 Suppl 1():35-42. PubMed ID: 8625542
[TBL] [Abstract][Full Text] [Related]
45. Intravenous immunoglobulin and hepatitis C virus: the Boston episode.
Schneider LC; Jonas MM; Baron MJ; Mast EF; Alter MJ; Schonberger LB; Lambert S; Coleman P; Bresee JS
Clin Ther; 1996; 18 Suppl B():108-9. PubMed ID: 8930448
[No Abstract] [Full Text] [Related]
46. Intravenous immunoglobulins and hepatitis C transmission in healthy pregnant women.
Reznikoff-Etievant MF; de Lachaux Y; Marpeau L; Couroucé A
Lancet; 1992 Oct; 340(8825):986. PubMed ID: 1357402
[No Abstract] [Full Text] [Related]
47. Chronic hepatitis C after high-dose intravenous immunoglobulin.
Pawlotsky JM; Bouvier M; Deforges L; Duval J; Bierling P; Dhumeaux D
Transfusion; 1994 Jan; 34(1):86-7. PubMed ID: 8273141
[No Abstract] [Full Text] [Related]
48. Safety of intravenous immunoglobulin.
Shaw WL; Stewart RR
Lancet; 1987 Apr; 1(8538):928. PubMed ID: 2882333
[No Abstract] [Full Text] [Related]
49. Hepatitis C virus and intravenous immune globulin.
Mosley JW
JAMA; 1997 Feb; 277(8):627; author reply 627-8. PubMed ID: 9039875
[No Abstract] [Full Text] [Related]
50. Safety and side effects of i.v. immunoglobulin therapy.
Nydegger UE
Clin Exp Rheumatol; 1996; 14 Suppl 15():S53-7. PubMed ID: 8828949
[TBL] [Abstract][Full Text] [Related]
51. Safety considerations in IGIV utilization.
Siegel J
Int Immunopharmacol; 2006 Apr; 6(4):523-7. PubMed ID: 16504914
[TBL] [Abstract][Full Text] [Related]
52. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
Razvi S; Schneider L; Jonas MM; Cunningham-Rundles C
Clin Immunol; 2001 Dec; 101(3):284-8. PubMed ID: 11726220
[TBL] [Abstract][Full Text] [Related]
53. Immunoglobulin as a risk factor for contrast media nephrotoxicity.
Bassilios N; Mercadal L; Deray G
Nephrol Dial Transplant; 2001 Jul; 16(7):1513-4. PubMed ID: 11427658
[No Abstract] [Full Text] [Related]
54. Prevalence of hepatitis C in patients with primary antibody deficiency.
Webster AD; Brown D; Franz A; Dusheiko G
Clin Exp Immunol; 1996 Jan; 103(1):5-7. PubMed ID: 8565286
[TBL] [Abstract][Full Text] [Related]
55. Intravenous immune globulin in primary immunodeficiency.
Haeney M
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):11-5. PubMed ID: 8033427
[TBL] [Abstract][Full Text] [Related]
56. Non-A, non-B hepatitis after intravenous gammaglobulin.
Weiland O; Mattsson L; Glaumann H
Lancet; 1986 Apr; 1(8487):976-7. PubMed ID: 2871273
[No Abstract] [Full Text] [Related]
57. HCV infection in patients with primary defects of immunoglobulin production.
Quinti I; Pandolfi F; Paganelli R; el Salman D; Giovannetti A; Rosso R; Oliva A; Rainaldi L; Aiuti F
Clin Exp Immunol; 1995 Oct; 102(1):11-6. PubMed ID: 7554376
[TBL] [Abstract][Full Text] [Related]
58. Human immunoglobulin (KIOVIG®/GAMMAGARD LIQUID®) for immunodeficiency and autoimmune diseases: an observational cohort study.
Blažek B; Misbah SA; Soler-Palacin P; McCoy B; Leibl H; Engl W; Empson V; Gelmont D; Nikolov N
Immunotherapy; 2015; 7(7):753-63. PubMed ID: 25865232
[TBL] [Abstract][Full Text] [Related]
59. A likelihood-based method of identifying contaminated lots of blood product.
Reilly M; Lawlor E
Int J Epidemiol; 1999 Aug; 28(4):787-92. PubMed ID: 10480712
[TBL] [Abstract][Full Text] [Related]
60. [Liver function tests, hepatitis A, B, C markers and HIV antibodies in patients with Basedow's ophthalmopathy treated with intravenous immunoglobulins].
Antonelli A; Neri S; Gasperini L; Alberti B; Saracino A; Gambuzza C; Agostini S; Baschieri L
Clin Ter; 1992 Sep; 141(9 Pt 2):55-61. PubMed ID: 1468200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
